GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Junshi Biosciences Co Ltd (FRA:8SJ) » Definitions » Cash, Cash Equivalents, Marketable Securities

Shanghai Junshi Biosciences Co (FRA:8SJ) Cash, Cash Equivalents, Marketable Securities : €382.6 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shanghai Junshi Biosciences Co Cash, Cash Equivalents, Marketable Securities?

Shanghai Junshi Biosciences Co's quarterly cash, cash equivalents, marketable securities declined from Jun. 2024 (€424.05 Mil) to Sep. 2024 (€387.67 Mil) but then stayed the same from Sep. 2024 (€387.67 Mil) to Dec. 2024 (€382.64 Mil).

Shanghai Junshi Biosciences Co's annual cash, cash equivalents, marketable securities declined from Dec. 2022 (€812.01 Mil) to Dec. 2023 (€485.22 Mil) and declined from Dec. 2023 (€485.22 Mil) to Dec. 2024 (€382.64 Mil).


Shanghai Junshi Biosciences Co Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Shanghai Junshi Biosciences Co's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Junshi Biosciences Co Cash, Cash Equivalents, Marketable Securities Chart

Shanghai Junshi Biosciences Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only 425.50 486.96 812.01 485.22 382.64

Shanghai Junshi Biosciences Co Quarterly Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 485.22 582.46 424.05 387.67 382.64

Shanghai Junshi Biosciences Co Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Shanghai Junshi Biosciences Co  (FRA:8SJ) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Shanghai Junshi Biosciences Co Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Shanghai Junshi Biosciences Co's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Junshi Biosciences Co Business Description

Industry
Traded in Other Exchanges
Address
No. 987 Cai Lun Road, Level 4, Pilot Free Trade Zone, Shanghai, CHN
Shanghai Junshi Biosciences Co Ltd is mainly engaged in innovation-driven biopharmaceutical business. The company's main products include teriprizumab injection, Etesevimab, adalimumab injection, and other drugs, which are used to treat malignant tumors, autoimmune system diseases, chronic metabolic diseases, nervous system diseases, and infectious diseases. The group's operations are mainly located in the PRC and the United States of America.

Shanghai Junshi Biosciences Co Headlines

No Headlines